Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;28(4):614-9.
doi: 10.3346/jkms.2013.28.4.614. Epub 2013 Mar 27.

Clinical characteristics of 75 patients with leukemia cutis

Affiliations

Clinical characteristics of 75 patients with leukemia cutis

Yeon Soo Kang et al. J Korean Med Sci. 2013 Apr.

Abstract

Leukemia cutis (LC) is defined as a neoplastic leukocytic infiltration of the skin. Few clinical studies are available on recent trends of LC in Korea. The purpose of this study was to analyze the clinical features and prognosis of LC in Korea and to compare findings with previous studies. We performed a retrospective study of 75 patients with LC and evaluated the patients' age and sex, clinical features and skin lesion distribution according to the type of leukemia, interval between the diagnosis of leukemia and the development of LC, and prognosis. The male to female ratio was 2:1, and the mean age at diagnosis was 37.6 yr. The most common cutaneous lesions were nodules. The most commonly affected site was the extremities in acute myelocytic leukemia and chronic myelocytic leukemia except for acute lymphocytic leukemia. Compared with previous studies, there was an increasing tendency in the proportion of males and nodular lesions, and LC most often occurred in the extremities. The prognosis of LC was still poor within 1 yr, which was similar to the results of previous studies. These results suggest that there is a difference in the clinical characteristics and predilection sites according to type of leukemia.

Keywords: Clinical Characteristics; Leukemia Cutis; Prognosis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Gross manifestation on face. (A) Asymptomatic, multiple, variable-sized, erythematous papules on the face. (B) Painful, oozing, erythematous, erosive patches on the cheek. (C) Tender, crusted plaque on the chin.
Fig. 2
Fig. 2
Gross skin lesions on the trunk or extremities. (A) Multiple, erythematous nodules on the trunk. (B) Multiple, erythematous nodules on the whole body. (C) Pruritic, erythematous papules on both extremities. (D) Solitary, reddish-brown mass on the ankle.

References

    1. Costello MJ, Canizares O, Montague M, Buncke CM. Cutaneous manifestations of myelogenous leukemia. AMA Arch Derm. 1955;71:605–614. - PubMed
    1. Wagner G, Fenchel K, Back W, Schulz A, Sachse MM. Leukemia cutis - epidemiology, clinical presentation, and differential diagnoses. J Dtsch Dermatol Ges. 2012;10:27–36. - PubMed
    1. Cho KH, Jeon HP, Kim JA, Lee SK, Park SH, Kim BK. A clinicopathological study of leukemia cutis. Korean J Dermatol. 1990;28:321–330.
    1. Jang IG, Lee DW, Han CW, Kim CC, Cho BK. A clinical observation on leukemia cutis. Korean J Dermatol. 1996;34:507–514.
    1. Jang KA, Chi DH, Choi JH, Sung KJ, Moon KC, Koh JK. Leukemia cutis: a clinico-pathologic study of 23 patients. Korean J Dermatol. 2000;38:15–22.

MeSH terms